There’s no doubt that bronchiectasis is becoming more recognised in clinical practice and evidence for its treatment is evolving, but questions remain around the burden of disease in Australia and the impact of long-term macrolides on bacterial resistance, Australian respiratory physicians say. Writing in a review of the chronic lung condition published in this week’s ...
Adult bronchiectasis management is evolving: 9 new recommendations
By Nicola Garrett
21 Aug 2018